Form 4 for RMD ResMed|
Accepted 2022-11-02 00:00:00 ET · period of report 2022-10-31 · accession 0001127602-22-024789 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-02 | 2022-10-31 | RMD | FARRELL PETER C | Dir | G - Gift | $0.00 | -4,550 | 178.5K | -2% | $0 | |
| 2022-11-02 | 2022-10-31 | RMD | FARRELL PETER C | Dir | S - Sale | $221.98 | -9,050 | 183.1K | -5% | -$2.01M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2022-10-31 | G | D | 4,550 | $0.00 | 178,502 | D | — | — | |
| 2 | Common | ResMed Common Stock | 2022-10-31 | S | D | 9,050 | $221.98 | 183,052 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $217.65 to $224.11. The price reported above reflects the weighted average sale price. |